Ultomiris (ravulizumab)

£218.90£7,296.67

Ultomiris (ravulizumab) is a prescription medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria (PNH) and adults and children with atypical haemolytic uraemic syndrome (aHUS).

MANUFACTURER

Alexion Pharmaceuticals

USAGE

Intravenous

MEDICINE APPROVED BY

  • European Medical Agency (EMA)

  • Food and Drug Administration (FDA)

    PATIENTS HELPED

    • Over 1.2 million patients reached

    • More than 11,000 patients helped

    • 100% successful deliveries to 88 countries

This content has been reviewed by a Medical Doctor.
ULTOMIRIS (RAVULIZUMAB) Package

One vial of 300 mg/30 ml (10 mg/ml), One vial of 1,100 mg/11 ml (100 mg/ml)

Reviews

There are no reviews yet.

Be the first to review “Ultomiris (ravulizumab)”

Your email address will not be published. Required fields are marked *

Shopping Cart